Universal Corp (UVV) Notice: 10,000 Shares Proposed Sale on NYSE

Rhea-AI Filing Summary

Universal Corporation (UVV) notice of proposed sale: an individual plans to sell 10,000 common shares on or about 08/26/2025 on the NYSE with an aggregate market value reported as $554,458.00. The filing shows the shares were acquired from the issuer as equity compensation: 6,999 performance shares granted on 05/30/2025 and 3,001 restricted stock awards granted on 06/02/2025, with payment characterized as equity compensation. The filer reports 24,886,204 shares outstanding for the class and indicates no sales by the same person in the prior three months.

Insights

Corporate Governance Expert

TL;DR: An insider plans a routine sale of recently issued equity compensation totaling 10,000 shares; not necessarily material to UVV's operations.

The notice documents a proposed sale of equity compensation shortly after grant dates, which is common when recipients liquidate portions of awards for diversification or tax purposes. The filer certifies no undisclosed material information. Because the position represents a small fraction of the reported 24.9 million shares outstanding (about 0.04%), the direct governance impact appears limited. However, observers often monitor timing relative to grant dates and any trading plans, which are not detailed here.

Securities Analyst

TL;DR: The transaction size ($554,458) is modest relative to typical market capitalization and likely neutral for price impact.

The filing reports an approximate market value of $554,458 for 10,000 shares to be sold on the NYSE around 08/26/2025. Acquisition entries show awards granted on 05/30/2025 and 06/02/2025, classified as equity compensation. No prior sales by this person in the past three months were reported. Given the small share count versus the issuer's outstanding common shares, the sale is unlikely to materially affect liquidity or valuation on its own.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	10000	554458.00	24886204	08/26/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/30/2025	Performance Shares	Issuer			6999	05/30/2025	Equity Compensation
Common	06/02/2025	Restricted Stock Award	Issuer			3001	06/02/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being proposed for sale in the UVV Form 144?

The filer proposes to sell 10,000 common shares of Universal Corporation on or about 08/26/2025 on the NYSE with an aggregate market value of $554,458.00.

How were the shares the filer plans to sell acquired?

The shares were acquired from the issuer as equity compensation: 6,999 performance shares on 05/30/2025 and 3,001 restricted stock awards on 06/02/2025.

Does the filing report any other sales by this person in the past three months?

No. The form states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

What representation does the filer make about material information?

By signing, the person represents they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.

Where will the proposed sale be executed?

The sale is listed to be executed on the New York Stock Exchange (NYSE) through Charles Schwab & Co., Inc.